+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
ADMA Biologics Inc - logo

ADMA Biologics is a late stage biopharmaceutical company that develops specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

From
Bioengineered Protein Drugs Global Market Report 2024 - Product Thumbnail Image

Bioengineered Protein Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Plasma Therapeutics Market 2022-2026 - Product Thumbnail Image

Plasma Therapeutics Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
From
Plasma Therapy Global Market Report 2024 - Product Thumbnail Image

Plasma Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Convalescent Plasma Therapy Global Market Report 2024 - Product Thumbnail Image

Convalescent Plasma Therapy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Plasma Protein Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Plasma Protein Therapeutics Market Report and Forecast 2024-2032

  • Report
  • October 2023
  • 140 Pages
  • Global
From
Plasma Derived Therapy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Plasma Derived Therapy Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
From
From
Loading Indicator